Lymphoma in Sjogren's syndrome
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Drosos, Alexandros A. | en |
dc.contributor.author | Papadimitriou, C. | en |
dc.contributor.author | Talal, N. | en |
dc.contributor.author | Moutsopoulos, H. M. | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Drosos, Alexandros A. | en |
dc.creator | Papadimitriou, C. | en |
dc.creator | Talal, N. | en |
dc.creator | Moutsopoulos, H. M. | en |
dc.date.accessioned | 2018-06-22T09:54:17Z | |
dc.date.available | 2018-06-22T09:54:17Z | |
dc.date.issued | 1992 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42285 | |
dc.description.abstract | Sjogren's syndrome is an autoimmune disease with a known predisposition for lymphoma development. Eight of 120 patients with primary Sjogren's syndrome followed at the University of loannina over the past 7 years developed non‐Hodgkin's lymphoma diagnosed according to the Kiel classification. The lymphomas differed by location and grading. Six were called low grade (immunocytoma) and two intermediate grade non‐Hodgkin's lymphomas. Five of the immunocytomas involved the minor salivary or lacrimal glands. Immunoperoxidase staining for light chains revealed monoclonal populations. Two patients showed spontaneous regression not previously reported in Sjogren's syndrome. Thus, in Sjogren's syndrome, low grade non‐Hodgkin's lymphomas and especially immunocytomas are the most common lymphomas. These lymphomas tend to evolve very slowly and may regress spontaneously. Given these facts, a conservative approach to treatment is indicated in those patients with only localized disease. © 1992 Wiley‐Liss, Inc. Copyright © 1992 Wiley‐Liss, Inc., A Wiley Company | en |
dc.language.iso | eng | en |
dc.source | Medical and pediatric oncology | en |
dc.subject | Article | en |
dc.subject | Human | en |
dc.subject | 80 and over | en |
dc.subject | Aged | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Female | en |
dc.subject | Priority journal | en |
dc.subject | Clinical article | en |
dc.subject | Human tissue | en |
dc.subject | Nonhodgkin lymphoma | en |
dc.subject | Genotype | en |
dc.subject | Lymphoma | en |
dc.subject | Cancer grading | en |
dc.subject | Carcinogenesis | en |
dc.subject | Spontaneous | en |
dc.subject | Sjogren's syndrome | en |
dc.subject | Cancer localization | en |
dc.subject | Middle age | en |
dc.subject | Cancer classification | en |
dc.subject | Immunoperoxidase staining | en |
dc.subject | Tumor regression | en |
dc.subject | Tumor biopsy | en |
dc.subject | Lymphoma | en |
dc.subject | Sjoegren syndrome | en |
dc.subject | Autoimmunity | en |
dc.subject | Immunoenzyme techniques | en |
dc.subject | Conservative treatment | en |
dc.subject | Autoimmune disease | en |
dc.subject | Autoimmune diseases | en |
dc.subject | Case report | en |
dc.subject | Immunocytoma | en |
dc.subject | Immunoglobulin light chain | en |
dc.subject | Intermediate-grade | en |
dc.subject | Lacrimal gland | en |
dc.subject | Low-grade | en |
dc.subject | Lymphoma development | en |
dc.subject | Remission | en |
dc.subject | Salivary gland | en |
dc.subject | Spontaneous regression | en |
dc.title | Lymphoma in Sjogren's syndrome | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1002/mpo.2950200403 | |
dc.description.volume | 20 | |
dc.description.issue | 4 | |
dc.description.startingpage | 279 | |
dc.description.endingpage | 283 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Drosos, Alexandros A. [0000-0002-2232-0326] | |
dc.contributor.orcid | Moutsopoulos, H. M. [0000-0003-3287-4821] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-2232-0326 | |
dc.gnosis.orcid | 0000-0003-3287-4821 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |